| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $22,165,228 ) (Continued on the next page) |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL166733 | Biomarkers of Habitual Short Sleep and Related Cardiometabolic Risk | 000 | 2 | NIH | 1/14/2025 | $26,622 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM153175 | Out of the shadows: Illuminating mammalian histidine phosphorylation | 001 | 2 | NIH | 1/8/2025 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AI168714 | Cellular mechanisms linking the intestine to inflammation involving non-intestinal organs | 000 | 2 | NIH | 11/1/2024 | $186,725 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U4C49934 | Pediatric Mental Health Care Access Program | 03 | 2 | HRSA | 1/17/2025 | $500,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | NUR3DD000102 | The Utah Registry of Autism and Developmental Disabilities: Enhancing Public Health Surveillance of Autism Spectrum Disorder in Utah through the Autism and Developmental Disabilities Monitoring (ADDM) | 00 | 3 | CDC | 12/16/2024 | $875,838 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | TA248955 | Primary Care Training and Enhancement - Residency Training in Mental and Behavioral Health | 01 | 3 | HRSA | 1/8/2025 | $494,684 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG074535 | LOOH-induced muscle atrophy with age | 000 | 4 | NIH | 12/6/2024 | $478,750 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | H7600470 | Ryan White Part C Outpatient EIS Program | 00 | 29 | HRSA | 12/4/2024 | $292,696 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AT012229 | Physical Therapy Integrated with Mindfulness for Patients with Chronic Musculoskeletal Pain and Long-Term Opioid Treatment | 000 | 3 | NIH | 11/27/2024 | $479,708 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01MD017719 | Race and Medicare-Medicaid Dual Enrollment Disparities in Access to Quality and Intensity of Post-Acute Rehabilitation Care and Health Outcomes in Patients with Stroke | 000 | 4 | NIH | 12/2/2024 | $721,553 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24HL147018 | 2/2: AZithromycin Therapy in Preschoolers with a Severe Wheezing Episode Diagnosed at the Emergency Department (AZ-SWED) | 000 | 5 | NIH | 11/26/2024 | $505,281 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21HD110713 | Sensory Integration for Spatial Navigation After Concussion | 000 | 2 | NIH | 12/3/2024 | $170,897 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES032553 | Role of Surfactant Protein-C Mutation and Ozone Exposure in the Exacerbation of Pulmonary Fibrosis | 000 | 5 | NIH | 11/6/2024 | $383,172 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA121118 | A High-Throughput Model for Human Melanoma | 000 | 15 | NIH | 11/7/2024 | $260,775 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI173406 | Early life regulation of microbiota specific thymic T cell development | 000 | 3 | NIH | 11/1/2024 | $792,545 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21CA286375 | Quantitative evaluation of focused ultrasound thermal therapy on immunogenic cell death in breast cancer | 000 | 2 | NIH | 11/4/2024 | $194,387 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI175494 | Mechanisms of T cell persistence during chronic autoimmunity | 000 | 2 | NIH | 10/31/2024 | $648,623 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F30CA278348 | Metabolic Obesity Phenotypes and Obesity-related Cancer Survival | 000 | 2 | NIH | 11/14/2024 | $53,974 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | AY2AX000070 | Rural Huntsman at Home: Maneuvering a Paradigm Shift in Cancer Care | 000 | 1 | NIH | 11/15/2024 | $3,955,826 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R35GM148283 | Symbiosis and Chemical Diversity Generation | 001 | 3 | NIH | 1/16/2025 | $486,266 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR081006 | Sex Hormone Supplementation and Rotator Cuff Repair: A Preliminary Randomized Trial | 000 | 3 | NIH | 11/8/2024 | $152,460 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01ES024681 | BIOLOGICAL FATE AND BIOCOMPATIBILITY OF SILICA-BASED NANOCONSTRUCTS | 000 | 14 | NIH | 11/15/2024 | $461,025 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL167866 | Pathobiological mechanisms of cardiac disease in PGM1-CDG | 000 | 2 | NIH | 11/14/2024 | $586,682 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AI162929 | Targeting OCA-B in multiple sclerosis | 000 | 4 | NIH | 1/9/2025 | $399,740 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL177965 | Channelopathies of Inflammation | 000 | 1 | NIH | 1/10/2025 | $618,126 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21AR083686 | Quantitative magnetic resonance imaging in patients with femoroacetabular impingement syndrome | 000 | 2 | NIH | 12/4/2024 | $243,936 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00EY031737 | Exosomes and Conventional Outflow Homeostasis | 000 | 5 | NIH | 12/11/2024 | $249,000 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01NS122184 | Personalized Profiles of Pathology in Pediatric Traumatic Brain Injury | 000 | 4 | NIH | 12/12/2024 | $562,854 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01DK126903 | Validation and Identification of Genetic Variants in Peyronie's and Dupuytren's Disease that Predispose to Fibrosis and Inflammation | 000 | 4 | NIH | 12/12/2024 | $496,505 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R00NS114107 | Characterization of the molecular and cellular mechanisms underlying the sickness symptoms | 000 | 5 | NIH | 12/12/2024 | $203,421 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG077751 | Integrative Mechanisms of Vascular Aging | 000 | 3 | NIH | 12/9/2024 | $413,711 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32GM157872 | Generality-Oriented Development of Novel Methods for the Synthesis of Enantioenriched Sulfondiimines Using Data Science | 000 | 1 | NIH | 12/9/2024 | $73,408 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32GM157872 | Generality-Oriented Development of Novel Methods for the Synthesis of Enantioenriched Sulfondiimines Using Data Science | 001 | 1 | NIH | 12/9/2024 | $0 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01HL171686 | Novel Gene Therapy For Chronic Ischemic Heart Failure | 000 | 2 | NIH | 12/17/2024 | $680,971 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K12HD047349 | Pediatric Critical Care and Trauma Scientist Development Program (PCCTSDP) | 000 | 22 | NIH | 12/13/2024 | $846,375 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | T35HL007744 | Short-term Training: Students in Health Professional Schools | 000 | 30 | NIH | 12/14/2024 | $41,599 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K23DA062174 | Evaluating an Interdisciplinary Intervention to Improve Transitions to Primary Care for Hospitalized Patients with Substance Use Disorders | 000 | 1 | NIH | 12/13/2024 | $210,600 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R37CA263505 | SOX2 acts in the 3D genome of squamous cancer | 000 | 2 | NIH | 12/19/2024 | $367,201 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21HL172288 | Overcoming explainability and data availability barriers to broad application of ECG ML screening with a system-wide ECG dataset | 000 | 2 | NIH | 12/13/2024 | $115,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | U24NS107228 | UT StrokeNet | 000 | 7 | NIH | 12/16/2024 | $369,714 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA244583 | A Leukemia Cell-Specific Coiled-Coil Protein for Treatment of Chronic Myeloid Leukemia | 000 | 5 | NIH | 12/16/2024 | $313,959 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AG076748 | Tissue senescence and age-associated metabolic dysfunction: the role of immune cell mediated inflammation | 000 | 3 | NIH | 12/20/2024 | $401,253 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA131261 | Studying the initiation, progression and therapy of lung cancer in mouse models | 000 | 13 | NIH | 11/21/2024 | $346,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA131261 | Studying the initiation, progression and therapy of lung cancer in mouse models | 001 | 13 | NIH | 12/2/2024 | $12,280 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R21NS137105 | Defining the contribution from endothelial cell sphingolipid metabolism to outcomes of acute ischemic stroke in mice | 000 | 1 | NIH | 11/20/2024 | $192,500 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | K01AI173385 | Leveraging within-host M. tuberculosis diversity data to enhance transmission inference | 000 | 3 | NIH | 11/19/2024 | $132,057 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | F32GM154442 | A Data-Driven Approach to Protein Engineering of Aminotransferase ARO8 | 000 | 1 | NIH | 11/21/2024 | $73,828 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01AR076489 | EphB/EphrinB signaling in Systemic Sclerosis | 000 | 5 | NIH | 11/22/2024 | $335,251 |
| | 2025 | 2025 | UNIVERSITY OF UTAH | 201 PRESIDENTS CIR | SALT LAKE CITY | UT | 84112-9049 | SALT LAKE | USA | R01CA212415 | Transcriptional Regulation of Lung Cancer Identity | 000 | 8 | NIH | 11/20/2024 | $346,500 |
|
